Funding search · EIN 953772528 · Irvine, CA

Pediatric Cancer Research Foundation

A grantmaking public charity (files IRS Form 990, Schedule I). Charities like this often run real grant programs with application cycles.

60
grants reported
$5.9M
total given
2022–2024
filing years
$50,000
median grant

Based on grants this organization reported to the IRS for tax years 20222024. This is what they filed, not a complete record of their giving, and recent years may be incomplete because filings lag.

What they fund

pediatriccancercellhighpatientsresearchtargetingcare

Funder website ↗Full IRS filings ↗How this is builtReport an error

Funding pattern

What this funder pays for, at what size, and how to position adjacent work. Read from their filings, with every number checked against the record.

Sign in to analyze this funder’s giving pattern. Free in early access.

8 grants matching “glioma · $404,007

  • $37,500

    Children'S Hospital of Los Angeles · Los Angeles, CA · 2024

    Preclinial study to translate therapy using dna hypomethylating agents for pediatric high grade gliomas

  • $37,500

    Children'S Hospital Los Angeles · Los Angeles, CA · 2024

    Preclinial study to translate therapy using dna hypomethylating agents for pediatric high grade gliomas

  • $30,000

    Children'S Hospital of Philadelphia · Philadelphia, PA · 2024

    Elucidating how nf1 loss cooperates with setd2 to drive pediatric high-grade glioma formation

  • $25,000

    Children'S Hospital of Los Angeles · Los Angeles, CA · 2024

    Project to leverage the power of the immune system to fight pediatric high-grade glioma

  • $74,007

    University of Alabama Birmingham · Birmingham, AL · 2023

    Intranasal delivery of targeting nanoliposomal therapeutics for pediatric glioma

  • $75,000

    University of Alabama at Birmingham · Birmingham, AL · 2022

    Enhancement of immunovirotherapy with directed drug delivery for treatment of pediatric high-grade glioma

  • $75,000

    Ann & Robert Lurie Children'S Hospital · Chicago, IL · 2022

    Intranasal delivery of targeting nanoliposomal therapeutics for pediatric glioma

  • $50,000

    Lucille Packard Children'S Hospital · Palo Alto, CA · 2022

    Effective therapy for pediatric high-grade gliomas

Top recipients

Repeat recipients are the strongest signal of whether a funder has an open door or quietly re-funds the same organizations.

  • New York Medical College4 grants · $2.3M
  • Memorial Sloan Kettering3 grants · $375,000
  • Dana Farber3 grants · $255,000
  • Stanford University3 grants · $240,000
  • V Foundation1 grant · $204,000
  • City of Hope4 grants · $200,000
  • University of California San Francisco2 grants · $160,000
  • Ucsf2 grants · $155,000
  • Children'S Hospital of Philadelphia2 grants · $155,000
  • Baylor College of Medicine2 grants · $150,000

Giving over time

$1.9M
2022
$1.6M
2023
$2.4M
2024

Grant history

All 60 reported grants, largest first.

  • $900,000

    New York Medical College · Valhalla, NY · 2022

    Pediatric cancer research foundation laboratory at nymc

  • $550,000

    New York Medical College · Valhalla, NY · 2024

    Pediatric cancer research foundation laboratory at new york medical college

  • $550,000

    New York Medical College · Valhalla, NY · 2023

    Pediatric cancer research foundation laboratory at new york medical college

  • $275,000

    New York Medical College · Valhalla, NY · 2024

    Pediatric cancer research foundation laboratory at new york medical college

  • $204,000

    V Foundation · Cary, NC · 2024

    Cancer research

  • $150,000

    Memorial Sloan Kettering · New York, NY · 2024

    Towards curative epigenetic therapies of refractory pediatric sarcomas

  • $150,000

    Memorial Sloan Kettering · New York, NY · 2023

    Towards curative epigenetic therapies of refractory pediatric sarcomas

  • $125,000

    Children'S Hospital of Philadelphia · Philadelphia, PA · 2022

    Precision medicine to exploit bcl2-family survival dependencies in neuroblastoma

  • $125,000

    University of Texas Md Anderson Cancer Center · Houston, TX · 2022

    Combining a novel dendritic cell vaccine with checkpoint blockade for osteosarcoma therapy

  • $115,000

    Stanford University · Palo Alto, CA · 2023

    Targeting mitochondrial pathways in pediatric aml

  • $115,000

    Ucsf · San Francisco, CA · 2023

    Tacl2020-004: a risk stratified clinical trial for patients with newly diagnosed juvenile myelomonocytic leukemia

  • $115,000

    University of California San Francisco · San Francisco, CA · 2022

    Modulating the immune microenvironment in pediatric acute myeloid leukemia

  • $105,000

    Dana Farber · Boston, MA · 2023

    Prospective validation of a prognostic liquid biopsy approach for pediatric ewing sarcoma

  • $100,000

    City of Hope · Duarte, CA · 2024

    Single-cell dissecting of high-risk b-cell acute lymphoblastic leukemia

  • $100,000

    Dana Farber · Boston, MA · 2024

    Advancing liquid biopsies to the clinic for patients with ewing sarcoma

  • $100,000

    Johns Hopkins · Baltimore, MD · 2024

    Targeting shp2 as a therapeutic strategy in fusion-negative rhabdomyosarcoma

  • $100,000

    Stanford · Palo Alto, CA · 2024

    Targeting mitochondrial pathways in pediatric aml

  • $91,717

    Md Anderson · Houston, TX · 2023

    Combining a novel dendritic cell vaccine with checkpoint blockade for osteosarcoma therapy

  • $75,000

    Memorial Sloan Kettering · New York, NY · 2024

    Towards curative epigenetic therapies of refractory pediatric sarcomas

  • $75,000

    Baylor College of Medicine · Houston, TX · 2023

    Off-the-shelf combination cancer immunotherapy with oncolytic adeno-immunotherapy and car nk cell therapy for pediatric sarcoma

  • $75,000

    Case Western · Clevenland, OH · 2023

    Use of mr fingerprinting for determining response to immunotherapy in pediatric brain tumors

  • $75,000

    Ann & Robert Lurie Children'S Hospital · Chicago, IL · 2022

    Intranasal delivery of targeting nanoliposomal therapeutics for pediatric glioma

  • $75,000

    Baylor College of Medicine · Houston, TX · 2022

    Off-the-shelf combination cancer immunotherapy with oncolytic adeno-immunotherapy and car nk cell therapy for pediatric sarcoma

  • $75,000

    Dana-Farber Cancer Institute · Boston, MA · 2022

    Prospective validation of a prognostic liquid biopsy approach for pediatric ewing sarcoma

  • $75,000

    Stanford University · Palo Alto, CA · 2022

    Development of small molecules to target cred:cbp interaction for treatment of aml

  • $75,000

    University of Alabama at Birmingham · Birmingham, AL · 2022

    Enhancement of immunovirotherapy with directed drug delivery for treatment of pediatric high-grade glioma

  • $74,007

    University of Alabama Birmingham · Birmingham, AL · 2023

    Intranasal delivery of targeting nanoliposomal therapeutics for pediatric glioma

  • $70,000

    UCLA Foundation · Los Angeles, CA · 2023

    Research into multidisciplinary approach to significantly and positively improve the quality of life of and quality of care for children and young people with cancer.

  • $55,000

    UCLA Foundation · Los Angeles, CA · 2022

    Research into multidisciplinary approach to significantly and positively improve the quality of life and quality of care for children and young people with cancer

  • $50,000

    City of Hope · Duarte, CA · 2024

    Single-cell dissecting of high-risk b-cell acute lymphoblastic leukemia

  • $50,000

    Dana Farber · Boston, MA · 2024

    Prospective validation of a prognostic liquid biopsy approach for pediatric ewing sarcoma

  • $50,000

    Johns Hopkins University · Baltimore, MD · 2024

    Targeting shp2 as a therapeutic strategy in fusion-negative rhabdomyosarcoma

  • $50,000

    Stanford University · Palo Alto, CA · 2024

    Targeting mitochondrial pathways in pediatric aml

  • $50,000

    Hope for Henry · Washington, DC · 2023

    Rewarding pediatric patients and elevating their care

  • $50,000

    Mayo Clinic · Rochester, MN · 2023

    Targeting transcriptional dependencies in atypical teratoid rhabdoid tumor

  • $50,000

    New York University School of Medicine · New York, NY · 2023

    Modulating the immune microenvironment in pediatric acute myeloid leukemia

  • $50,000

    University of Florida · Gainesville, FL · 2023

    Investigating the immune response to rna-lipid nanoparticle vaccines in a clinical trial for canines with osteosarcoma

  • $50,000

    Hope for Henry Foundation · Washington, DC · 2022

    Reinventing how hospitals care for seriously ill children and their families through innovative programs that entertain, reduce stress, and empower children to be active participants in their own care.

  • $50,000

    Lucille Packard Children'S Hospital · Palo Alto, CA · 2022

    Effective therapy for pediatric high-grade gliomas

  • $50,000

    Texas Children'S Hospital · Houston, TX · 2022

    Developing a sensitive method for cic fusion gene detection in sarcomas by customized genomic sequencing

  • $49,563

    Hope for Henry · Washington, DC · 2024

    Rewarding pediatric patients and elevating their care

  • $45,000

    University of California San Francisco · San Francisco, CA · 2024

    A risk stratified clinical trial for patients with newly diagnosed juvenile myelomonocytic leukemia

  • $40,000

    Ucsf · San Francisco, CA · 2024

    Tacl2020-004: a risk stratified clinical trial for patients with newly diagnosed juvenile myelomonocytic leukemia

  • $37,500

    Case Western · Clevenland, OH · 2024

    Use of mr fingerprinting for determining response to immunotherapy in pediatric brain tumors

  • $37,500

    Case Western · Clevenland, OH · 2024

    Use of mr fingerprinting for determining response to immunotherapy in pediatric brain tumors

  • $37,500

    Children'S Hospital Los Angeles · Los Angeles, CA · 2024

    Preclinial study to translate therapy using dna hypomethylating agents for pediatric high grade gliomas

  • $37,500

    Children'S Hospital of Los Angeles · Los Angeles, CA · 2024

    Preclinial study to translate therapy using dna hypomethylating agents for pediatric high grade gliomas

  • $32,000

    Children'S Hospital Los Angeles · Los Angeles, CA · 2024

    Research into multidisciplinary approach to significantly and positively improve the quality of life of and quality of care for children and young people with cancer

  • $30,000

    Children'S Hospital of Philadelphia · Philadelphia, PA · 2024

    Elucidating how nf1 loss cooperates with setd2 to drive pediatric high-grade glioma formation

  • $30,000

    Hope for Henry Foundation · Washington, DC · 2024

    Rewarding pediatric patients and elevating their care

  • $30,000

    Indiana University · Bloomington, IN · 2024

    Decoding metabolic dependencies of mpnsts and its microenvironment

  • $30,000

    Seattle Children'S Hospital · Seattle, WA · 2022

    Development of tunable on-off car t cells for safe and durable tumor control

  • $29,700

    Massachusetts General Hospital · Boston, MA · 2022

    Optimizing car t cell immunotherapy for pediatric rhabdomyosarcoma

  • $27,000

    Indiana University · Bloomington, IN · 2024

    Decoding metabolic dependencies of mpnsts and its microenvironment

  • $25,000

    Children'S Hospital of Los Angeles · Los Angeles, CA · 2024

    Project to leverage the power of the immune system to fight pediatric high-grade glioma

  • $25,000

    City of Hope · Duarte, CA · 2024

    Reporter t cell line generation

  • $25,000

    Ronald McDonald House Charities · Los Angeles, CA · 2024

    Wildfire recovery funding for families of cancer patients at the los angeles ronald mcdonald house

  • $25,000

    City of Hope · Duarte, CA · 2023

    Reporter t cell line generation

  • $25,000

    Ann & Robert Lurie Children'S Hospital · Chicago, IL · 2022

    Immunotherapy for dipg

  • $8,000

    Live Like Liv Foundation · Saratoga Springs, NY · 2024

    Supports children and families dealing with serious conditions

Grants already paid are the record; PaperOrbit reads your paper and finds the funders whose record matches it — then explains why.

Search funders like this one

Source: IRS Form 990, Schedule I, as filed by this organization. These are grants already paid. Grants paid directly to individuals are reported to the IRS only as totals, so they do not appear as named lines here.